Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dimethylfumarat, ATC D05BX02 für die Zeit 01.01.2026 - 31.12.2027
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dimethylfumarat, ATC D05BX02 für die Zeit 01.01.2026…”. Bids close on 1 November 2027. To qualify, bidders need at least one similar completed work and GST registration.
The work
Conclusion of non-exclusive discount agreements for the active substance Dimethylfumarat, ATC D05BX02, for the period 01.01.2026 - 31.12.2027.
- Submission of offer letter
- Acceptance of contractual terms
- Completion of contract annexes
Key facts
- Contract period
- 01.01.2026 - 31.12.2027
- Evaluation
- Selection criteria referenced as 'Siehe Antragsschreiben' (application letter).
What it takes to qualify
Worth a closer look
- § 130a Absatz 8 SGB V enables health insurance funds and pharmaceutical companies to conclude framework discount contracts for medicinal products
- The ARGE Dimethylfumarat consists of multiple health insurance funds: DAK-Gesundheit, Techniker Krankenkasse, Kaufmännische Krankenkasse, HEK, Hanseatische Krankenkasse, hkk, Handelskrankenkasse, BARMER
- The process is considered not to fall under cartel procurement law due to lack of selection decision
Experience
- At least 1 similar work — No specific experience requirements mentioned.
Certifications and registrations
GST registrationNo mention of GST registration in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- AngebotsschreibenSubmission via email to openhouse@dak.de.
- Anerkennung der vertraglichen Maßgaben der DAK-GesundheitSubmission via email to openhouse@dak.de.
- Anlagen 1 und 2 zum VertragAnlage 2 must be an Excel file, submission via email to openhouse@dak.de.